ATLANTA, July 15, 2025 /PRNewswire/ — Precision Aviation Group, Inc. (PAG), a leading provider of maintenance, repair, and overhaul (MRO) services as well as value-added solutions to the global aerospace and defense industries, today announced its expansion into the EMEA (Europe, Middle East, and Africa) region with the acquisition of Turner Aviation, a highly regarded aviation MRO services provider based in the United Kingdom.

The addition of Turner marks PAG’s first facility in the EMEA region and is part of the company’s broader global growth strategy. With this acquisition, PAG enhances its ability to serve customers in this region by providing expanded local support, faster turnaround times, and enhanced capabilities.

Founded in 1954 and headquartered in Glasgow, Scotland, Turner Aviation specializes in the repair and overhaul of a wide range of avionics, components, and fuel systems. Turner is a UK Civil Aviation Authority (CAA) and EASA Part 145 approved repair station and serves a diverse customer base across the EMEA region.

David Mast, President and CEO of PAG, commented: “The acquisition of Turner Aviation represents a significant milestone in the continued growth of PAG. Their deep technical expertise, strong customer relationships, long-serving leadership team and strategic location make it an ideal partner for PAG. We are excited to build on Turner’s impressive legacy.”

Douglas Muirhead, Managing Director of Turner Aviation, added: “We are thrilled to become part of the growing PAG family. This acquisition will not only provide Turner with enhanced resources and a global network but also allow us to better serve our customers.”

A bout Precision Aviation Group (PAG)
Precision Aviation Group (PAG) is a leading provider of maintenance, repair, and overhaul (MRO) and value-added supply chain services to the aerospace and defense industries. With 25 FAA-approved repair stations, 27 locations worldwide, 1,100+ employees, and over 1.2 million square feet of production/distribution facilities, PAG offers comprehensive MRO services on over 200,000 product lines. PAG supports operators in the Airline, Business and General Aviation (BGA), Military and Rotary Wing markets through its Inventory Supported Maintenance, Repair, and Overhaul (ISMRO®) business model. For more information, visit www.precisionaviationgroup.com

About Turner Aviation
Turner Aviation, established in 1954 and based in Glasgow, Scotland, is a UKCAA and EASA-approved MRO provider offering specialized services in the repair and overhaul of avionics, components, and fuel systems. Turner serves a diverse customer base across the EMEA region. For more information, visit www.turner-aviation.co.uk

Turner Aviation headquarters in Glasgow, Scotland

Logo – https://laotiantimes.com/wp-content/uploads/2025/07/precision_aviation_group_logo.jpg
Photo – https://laotiantimes.com/wp-content/uploads/2025/07/precision_aviation_group_turner_aviation_headquarters_in_glasgow.jpg
Photo – https://laotiantimes.com/wp-content/uploads/2025/07/turner_aviation_logo.jpg

New agricultural drones offer higher efficiency, improved safety, and better capabilities to support spraying, spreading — and now lifting

SHENZHEN, China, July 15, 2025 /PRNewswire/ — DJI, the world leader in civilian drones and creative camera technology, today announces the global launch of the DJI Agras T100, DJI Agras T70P, and DJI Agras T25P. The newest generation of DJI Agriculture’s popular spray drones builds on over 12 years of dedicated research and development. Not only can they carry heavier payloads, but these agricultural drones can also support multiple application scenarios with higher operational efficiency. Each drone features industry-leading safety systems and more intelligent features for fully automated operations.

“For more than a decade, DJI Agriculture has advanced precision farming globally with our advanced drone technology. With nearly 500,000 trained operators worldwide as of May, the industry is maturing, and the demand for spray drones continues to grow annually. Today, more than 500,000 DJI Agriculture drones are used to treat 300 types of crops in 100 countries, ” said Yuan Zhang, Head of Global Sales at DJI Agriculture. “With the next generation of DJI Agriculture drones, we continue to innovate how we farm and feed communities, while reducing the environmental costs to our planet.”

Tackle Bigger Jobs with the Agras T100

Designed for large-scale commercial growers, the Agras T100 can carry a maximum payload of 100 L for spraying,  150 L for spreading, or 100 kg for lifting, with the maximum operation speed increased to 20 m/s**.  Compared to its predecessor, it is twice as efficient for high-volume spraying and faster for large-capacity spreading. With an industry-leading safety system equipped with LiDAR, millimeter-wave radar, and a Penta-Vision system, it delivers an unparalleledly safe and intelligent operational experience.

Work More Efficiently with the Agras T70P

The Agras T70P features multiple upgrades to increase operational efficiency, with the maximum operation speed increased to 20 m/s**. It can carry a maximum payload of 70 L for spraying, 100 L for spreading, or 65 kg for lifting. At the same time, it offers the same flow rates and fine mist droplet size as the Agras T100, along with its new spreading system and lifting system. The Agras T70P is equipped with the Safety System 3.0, which features millimeter-wave radar and a Tri-Vision system for obstacle detection, smarter route selection, and significantly improved obstacle clearance rates.

Compact and Flexible for Solo Operations with the Agras T25P

The Agras T25P retains its predecessor’s compact and foldable design but offers the upgraded 25 kg high-precision screw feeder spreading system 4.0 and the Safety System 3.0. Ideal for solo operations, the Agras T25P is easy to transport, set up, and allows for fully automated operations in aerial mapping and plant protection.

New Training Program for Agriculture Drone Operations

DJI Agriculture now offers new pilot training courses under DJI Academy. The program will first be available in 15 countries in the Americas and Asia. Pilots will learn essential skills for operating agricultural drones, including crop protection spraying and spreading, safe piloting practices, and improving efficiency with maximum effectiveness.

Availability

The DJI Agras T100, T70P, and T25P will be available for sale globally starting in Southeast Asia and Latin America. For more information on local availability and pricing, please contact authorized DJI Agriculture dealers in your country or region. 

Learn more:
https://ag.dji.com/t100
https://ag.dji.com/t70p
https://ag.dji.com/t25p 

^*All data was measured using a production model in a controlled environment.
^**May vary in different markets due to local regulations.  

About DJI Agriculture

DJI Agriculture was established by DJI in 2015 with the mission to bring innovative drone technology to farming, making it more sustainable, efficient, and safer. DJI began investing in R&D for the advancement of spray drones in 2012, before it created a dedicated business unit for agriculture drones. As the leader of the drone industry, DJI is building a world by continuously promoting human advancement through products that add value to lives around the world in more profound ways than ever before. Today, an estimated 500,000 agricultural drones are in use worldwide to treat more than 300 types of crops in more than 100 countries.

DUBAI, UAE, July 15, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, announces the launch of its exclusive Fiat-to-Crypto Weekly Frenzy, a promotional event designed to welcome and reward new users exploring the crypto ecosystem. Running now until September 30, 2025, the campaign offers participants the chance to win a share of 20,000 USDT every week by completing simple trading and deposit tasks.

Bybit’s Peer-to-Peer (P2P) platform enables users to access over 300 cryptocurrencies using their local fiat currency, delivering fast, secure, and hassle-free transactions. From leading digital assets such as USDT, BTC, and ETH, to trending altcoins like DOGE and LAYER, Bybit P2P is designed to make crypto accessible to a wider global audience.

How the Event Works:

• Sign Up and Verify: New users register for a Bybit account and complete identity verification.
• Complete Tasks: Participants visit the Rewards Hub to complete simple deposit and spot trading activities, earning bonuses and lucky draw tickets.
• Join Weekly Draws: Each ticket serves as an entry for a chance to win a share of the weekly 20,000 USDT prize pool.

The goal of the Fiat-to-Crypto Weekly Frenzy is to create an exciting and rewarding experience for users who are new to the crypto space. Bybit explains that Bybit P2P simplifies the process of converting fiat to crypto and provides valuable incentives, encouraging users to explore digital assets safely and efficiently.

For more information or to register for the event, users may visit the Fiat-to-Crypto Weekly Frenzy event page.

#Bybit / #TheCryptoArk

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 70 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: media@bybit.com
For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

HONG KONG, July 15, 2025 /PRNewswire/ — GIBO Holdings Ltd. (NASDAQ: GIBO), a leader in smart content monetization technology, today announced the successful testing of GIBO Click’s multi-currency settlement and analytics engine on the fast-growing short-drama platform DramaFlow.

Launched in October 2024, DramaFlow focuses on delivering high-frequency, high-engagement vertical short dramas of 1 to 3 minutes. The platform targets global audiences with strong user bases in North America, Southeast Asia, and the Middle East, and supports diverse monetization models including IAP (in-app purchases), IAA (in-app ads), and subscription memberships.

As of June 2025, DramaFlow has:

• 1.4 million total users
• 120,000 daily active users
• Over 43 million total video views

GIBO Click Powers Performance & Viewer Insight

The successful implementation test allowed DramaFlow to leverage key modules of GIBO Click, including:

• Multi-Currency Settlement Engine: Streamlining transactions across diverse regions and user demographics
• Real-Time Viewer Analysis: Gaining audience insights and optimizing content placement for maximum engagement
• Flexible Commerce Layer: Supporting various monetization logics tailored to the platform’s global strategies

This integration reinforces GIBO Click’s role as an adaptive infrastructure for scaling short-drama ecosystems and enhances the user-to-value conversion loop.

Accelerating the Smart Entertainment Economy

With short-form platforms becoming cultural powerhouses, GIBO Click continues to enable intelligent content monetization at global scale. The DramaFlow trial marks another strategic deployment following earlier trials with platforms like Honey Reels, YouShort, and uDrama.

GIBO Click’s smart monetization tools are expected to continue rolling out across new geographies and partner platforms throughout 2025.

About GIBO Holdings Limited

GIBO Holdings Ltd. is a unique and integrated AIGC animation streaming platform with extensive functionalities provided to both viewers and creators that serves a broad community of young people across Asia to create, publish, share and enjoy AI-generated animation video content. With over 86 million registered users and advanced AI-powered tools, GIBO seeks to redefine the landscape of digital content creation.

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements also include, but are not limited to, statements regarding projections, estimates and forecasts of revenue and other financial and performance metrics, projections of market opportunity and expectations, the Company’s ability to scale and grow its business, the Company’s advantages and expected growth, the Company’s ability to source and retain talent, and the Company’s cash position, as applicable. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of the Company’s management and are not predictions of actual performance. These statements involve risks, uncertainties and other factors that may cause the Company’s actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by these forward-looking statements. Although the Company believes that it has a reasonable basis for each forward-looking statement contained in this press release, the Company cautions you that these statements are based on a combination of facts and factors currently known and projections of the future, which are inherently uncertain. The forward-looking statements in this press release represent the views of the Company as of the date of this press release. Subsequent events and developments may cause those views to change. Except as may be required by law, the Company does not undertake any duty to update these forward-looking statements.

Contact Information

Investor Relations:
Bill Zima
ICR, Inc.
William.zima@icrinc.com 

Media Relations:
Edmond Lococo
ICR, Inc.
Edmond.Lococo@icrinc.com

For more information and the latest updates, please visit:
https://www.globalibo.com/gibo-click/

BASEL, Switzerland and SEOUL, South Korea, July 15, 2025 /PRNewswire/ — OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for people and their families, today announced the appointment of Dr Andreas Niethammer, M.D., Ph.D., as Chief Medical Officer of Vaximm AG, an OSR Company developing a platform of orally administered target-specific T-cell activators, including VXM01, a clinical stage anti-VEGFR-2. .

Dr. Niethammer is an internationally recognized oncology expert with over two decades of experience in cancer immunotherapy, clinical development, and translational medicine. He previously held leadership roles at global biopharmaceutical companies including Fate Therapeutics, NantKwest (now Immunity Bio), Pfizer, and more recently Aardvark Therapeutics, and has played a pivotal role in the development of novel immuno-oncology platforms, including VXM01.

Vaximm was co-founded by Dr. Niethammer to advance and commercialize therapeutic candidates based on his original publications on the concept of oral T-cell vaccination while at the Scripps Research Institute (Nature, 2002). Under his leadership, Vaximm successfully advanced lead candidate, VXM01, into first-in-human clinical studies for both pancreatic cancer and glioblastoma.

“We are thrilled to welcome Dr. Niethammer back to Vaximm as CMO leading Vaximm’s clinical strategy,” said Dr. Constance Höfer, Chief Science Officer of OSRH. “His unique understanding of Vaximm’s foundational scientific concepts, combined with his deep global clinical development experience, perfectly place him to both continue the clinical advancement of the lead candidate VXM01, and also to drive platform and pipeline expansion in oncology as well as other disease areas.”

“I am honored to rejoin Vaximm at this exciting moment in its evolution,” said Dr. Niethammer. “With OSR Holdings’ support and resources, we are uniquely positioned to accelerate the development of powerful oral immunotherapies with the potential to improve outcomes for patients with difficult-to-treat cancers, as well as other diseases with high unmet needs where the Vaximm platform can potentially transform treatment options and outcomes.”

Dr. Niethammer received his M.D. and Ph.D. from the University of Heidelberg and currently serves as an associate professor of oncology at Heidelberg University. He has authored numerous peer-reviewed publications and is widely regarded as a leader in T-cell–based cancer vaccine development.

About Vaximm AG

Vaximm, a wholly owned subsidiary of OSR Holdings Inc., is a Swiss-German biotech company focused on the development of oral T-cell immunotherapies for cancer. Its proprietary platform is designed to activate targeted cytotoxic T-cell responses via oral administration. Vaximm’s lead program, VXM01, has completed Phase I/II clinical trials in pancreatic cancer and glioblastoma.

About OSR Holdings Inc.

OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare holding company dedicated to advancing biomedical innovation approaches to health and wellness to support global health outcomes. Through its subsidiaries, OSRH is engaged in immuno-oncology, regenerative biologics, and medical device distribution. OSRH’s vision is to acquire and operate a portfolio of innovative healthcare and wellness companies, improving patient care through cutting-edge research and development.

Contact Information
OSR Holdings, Inc.
Investor Relations
ir@osr-holdings.com 
+82-31-948-9419

Scientists Unveil 4DMedical Imaging Breakthrough that Spots Early Lung Disease Missed by Standard Tests

LOS ANGELES, July 15, 2025 /PRNewswire/ — Researchers at Vanderbilt University, Johns Hopkins University, University of Miami, and The Alfred Hospital studied the lungs of subjects including Veterans using technology developed by 4DMedical called X-ray Velocimetry Lung Ventilation Analysis Software (XV LVAS^®). Findings of the major, multi-center study were described in the article, “X-ray velocimetry provides temporally and spatially-resolved biomarkers of lung ventilation in small airways disease” published in the journal Respiratory Research and showed that 4DMedical’s unique lung imaging technology—XV LVAS— can detect early or subtle small airway disease typically undiagnosed with conventional testing.

“We’re now able to see the invisible,” says Dr. Bradley Richmond, a pulmonologist who along with Dr. Michael Lester co-led the study. “XV LVAS technology gives us a window into parts of the lung we’ve never been able to assess so precisely before. It could transform care for patients whose symptoms were previously a mystery.”

For decades, doctors have depended on breathing tests such as spirometry and CT scans to assess lung health. However, some conditions—particularly those impacting the smallest airways—often go undetected, leaving patients without clear diagnoses or effective treatment. Now, with 4DMedical’s XV LVAS technology, clinicians can securely upload fluoroscopy scans for advanced analysis. This innovative system produces detailed, real-time color maps that show how air flows through different lung regions as patients breathe. The results are delivered in clear, easy-to-read reports that integrate into existing clinical workflows.

XV LVAS provides clinicians with more functional lung detail than ever before—spatially resolved, actionable information for more optimized diagnosis and treatment decisions. Using fast, low-dose fluoroscopy XV LVAS offers a validated leap forward in lung diagnostics.

The study revealed several important insights. The XV analysis detected lung problems in patients—including combat veterans—even when standard breathing tests and CT scans indicated normal lung function. The technology also uncovered distinctive patterns linked to the early stages of chronic obstructive pulmonary disease (COPD), a condition affecting more than 15 million Americans. Furthermore, with its simple, low-radiation scan, XV LVAS allows patients to potentially avoid more invasive procedures, such as biopsies, while providing answers previously inaccessible with other methods.

Now, clinicians can detect disease invisible to spirometry, reduce unnecessary invasive testing, and provide personalized respiratory care—all supported by peer-reviewed research. XV LVAS can make a difference for millions of people dealing with unexplained shortness of breath, including military veterans, COPD patients, and others suffering from hidden forms of lung disease. Already cleared for clinical use in the United States and Australia, this innovative lung scan is now being studied in larger patient groups.

About 4DMedical
4DMedical is a global medical technology company at the forefront of developing tools for cardiopulmonary diagnostics. The company delivers an advanced suite of software imaging solutions that provide clinicians with comprehensive, non-invasive insights into lung and heart function. 4DMedical’s SaaS-based technologies enable the visualization and quantification of regional lung ventilation and other critical metrics, all using existing imaging equipment and low-dose scans. 4D is headquartered in Melbourne, Australia with U.S. offices in Los Angeles, California.

Veteran with biopsy-confirmed constrictive bronchiolitis, holds XV LVAS® color-mapped image of his lungs.

Logo – https://laotiantimes.com/wp-content/uploads/2025/07/4dmedical_logo.jpg
Photo – https://laotiantimes.com/wp-content/uploads/2025/07/4dmedical_veterans_with_lungs_photos_le_roy.jpg